Free certificates of participation are available upon successful completion of a learning quiz at: http://www.classmarker.com/online-test/start/?quiz=t665357ea6247811
Published: 04/23/2014 Length: 00:51:05
Dr. Fasano completed his medical training at the University of Naples in Italy, and in 1993 he founded the University of Maryland School of Medicine’s Division of Pediatric Gastroenterology and Nutrition. Ten years later, Dr. Fasano published the groundbreaking study in the Annals of Medicine that established the prevalence rate of celiac disease at one in 133 people in the U.S. In 1996 Dr. Fasano founded the Center for Celiac Research, the first celiac center in the United States, which is currently located at MassGeneral Hospital for Children. Clinical and research work at the Center has helped to identify the new disorder of non-celiac gluten sensitivity as a condition on the spectrum of gluten-related disorders. Dr. Fasano leads a team of researchers across nine countries and enjoys research partnerships with institutions around the world. He has published more than 200 peer-reviewed papers and he has received numerous awards for his translational science and other achievements. Dr. Fasano has been named one of America’s Top Doctors by Castle Connolly for five consecutive years (2007-2011) and was a 2005 finalist for the NIH Director’s Pioneer Award. In the year 2000 Dr. Fasano’s team discovered “zonulin,” the molecule which regulates intestinal permeability, also known as “leaky gut”, and their totally ground-breaking research has linked an overproduction of zonulin to the development of a series of autoimmune diseases, including type 1 diabetes, celiac disease and multiple sclerosis.
Microbiota Transfer Therapy Research Updates – Adults
Free webinar at 1 p.m. Eastern time (US), Wednesday, November 1, 2023 Learn research updates about how Microbiota Transfer Therapy—and its possible interactions with bacteria—may impact gastrointestinal and autism-related symptoms in adults.
Autism and Pica
Rescheduled for 1 pm Eastern Time (US), Wednesday, April 12, 2023: Tune in to hear Dean Alexander, Ph.D., discuss pica, the ingestion of non-food substances, which has received insufficient attention as a
Microbiota therapy may lead to lasting beneficial changes in the gut health of children with autism
Microbiota transfer therapy (MTT) may lead to long-term improvements in the gut health of children with autism spectrum disorders (ASD), according to a recent study by Khemlal Nirmalkar and colleagues at
Gastrointestinal Symptoms in Autistic Patients
Federico Balzola, MD, shares findings on gastrointestinal symptoms and pathological microscopic histological alterations found during upper and lower endoscopy with biopsies in more than 400 patients with autism.
Behavioral and Brain Signatures of Autism in Females
Kaustubh Supekar, Ph.D., examines recent findings about gender/sex differences in autism phenotypes and brain organization. He highlights the underrepresentation of females in autism and underscores the need for a large-scale science approach. The
Co-Occurring Conditions and Autism
Research suggests that individuals with autism experience some conditions―including underlying medical issues, neurodevelopmental differences, and mental health issues―more frequently than the general population. Learning about these potential medical needs can help you